Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Callan Jmb (CJMB) Liabilities and Shareholders Equity (2023 - 2025)

Historic Liabilities and Shareholders Equity for Callan Jmb (CJMB) over the last 3 years, with Q3 2025 value amounting to $7.7 million.

  • Callan Jmb's Liabilities and Shareholders Equity rose 2123.47% to $7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.7 million, marking a year-over-year increase of 389.79%. This contributed to the annual value of $5.1 million for FY2024, which is 4763.24% down from last year.
  • Latest data reveals that Callan Jmb reported Liabilities and Shareholders Equity of $7.7 million as of Q3 2025, which was up 2123.47% from $9.0 million recorded in Q2 2025.
  • In the past 5 years, Callan Jmb's Liabilities and Shareholders Equity ranged from a high of $9.7 million in Q4 2023 and a low of $5.1 million during Q4 2024
  • In the last 3 years, Callan Jmb's Liabilities and Shareholders Equity had a median value of $7.4 million in 2024 and averaged $7.5 million.
  • As far as peak fluctuations go, Callan Jmb's Liabilities and Shareholders Equity tumbled by 4763.24% in 2024, and later soared by 3957.22% in 2025.
  • Callan Jmb's Liabilities and Shareholders Equity (Quarter) stood at $9.7 million in 2023, then plummeted by 47.63% to $5.1 million in 2024, then surged by 52.21% to $7.7 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $7.7 million for Q3 2025, versus $9.0 million for Q2 2025 and $8.9 million for Q1 2025.